Overall, our findings suggest that NAFLD remains the main determinant of decline in kidney function in overweight/obese children, while the PNPLA3 rs738409 prosteatogenic variant has a small impact, if any. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.